AstraZeneca (NYSE: AZN) today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE